La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
GlaxoSmithKline Pharmaceuticals Gestione
Gestione criteri di controllo 2/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Bhushan Akshikar
Amministratore delegato
₹66.9m
Compenso totale
| Percentuale dello stipendio del CEO | 21.7% |
| Mandato del CEO | 1.8yrs |
| Proprietà del CEO | n/a |
| Durata media del management | 2yrs |
| Durata media del Consiglio di amministrazione | 6.4yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Can Manage Its Debt With Ease
Aug 29
The GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Aug 05Investors Appear Satisfied With GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Prospects As Shares Rocket 26%
Jun 01With EPS Growth And More, GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Makes An Interesting Case
May 05GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Popularity With Investors Is Clear
Apr 14Revenue Miss: GlaxoSmithKline Pharmaceuticals Limited Fell 5.9% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 15Is Now The Time To Put GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) On Your Watchlist?
Jan 18GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Investors Are Less Pessimistic Than Expected
Dec 28Here's Why We Think GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Might Deserve Your Attention Today
Oct 05Is GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Using Too Much Debt?
Sep 12GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Has A Pretty Healthy Balance Sheet
Mar 17Does GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Have A Healthy Balance Sheet?
Sep 02GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Seems To Use Debt Rather Sparingly
Mar 02The GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Share Price Is Up 32% And Shareholders Are Holding On
Mar 20Does GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) Have A Place In Your Dividend Portfolio?
Feb 27Declining Stock and Decent Financials: Is The Market Wrong About GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)?
Feb 06What Type Of Shareholders Make Up GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Share Registry?
Jan 11
GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Shareholders Have Enjoyed A 26% Share Price Gain
Dec 06Earnings Miss: GlaxoSmithKline Pharmaceuticals Limited Missed EPS By 48% And Analysts Are Revising Their Forecasts
Nov 01Tread With Caution Around GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) 1.3% Dividend Yield
Oct 29What Kind Of Shareholders Hold The Majority In GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Shares?
Sep 29If You Had Bought GlaxoSmithKline Pharmaceuticals (NSE:GLAXO) Stock A Year Ago, You Could Pocket A 30% Gain Today
Aug 30Is GlaxoSmithKline Pharmaceuticals Limited's (NSE:GLAXO) Recent Performancer Underpinned By Weak Financials?
Aug 02It Might Not Be A Great Idea To Buy GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) For Its Next Dividend
Jul 12Is GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO) At Risk Of Cutting Its Dividend?
Jul 07Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹6b |
| Mar 31 2024 | ₹67m | ₹15m | ₹6b |
| Dec 31 2023 | n/a | n/a | ₹5b |
| Sep 30 2023 | n/a | n/a | ₹6b |
| Jun 30 2023 | n/a | n/a | ₹6b |
| Mar 31 2023 | ₹34m | ₹4m | ₹6b |
Compensazione vs Mercato: La retribuzione totale di Bhushan ($USD 797.54K ) è circa la media per le aziende di dimensioni simili nel mercato Indian ($USD 641.91K ).
Compensazione vs guadagni: La retribuzione di Bhushan è aumentata di oltre il 20% nell'ultimo anno.
AMMINISTRATORE DELEGATO
Bhushan Akshikar
1.8yrs
Mandato
₹66,885,000
Compensazione
Mr. Bhushan Akshikar is Managing Director of GlaxoSmithKline Pharmaceuticals Limited from December 1, 2022. He served as Additional Director of GlaxoSmithKline Pharmaceuticals Limited since March 18, 2021...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| MD & Executive Director | 1.8yrs | ₹66.89m | Nessun dato | |
| Whole-Time Director & CFO | 2.4yrs | ₹68.92m | Nessun dato | |
| Executive Vice President of Human Resources | 3.8yrs | ₹37.40m | Nessun dato | |
| Vice President of Technology | less than a year | Nessun dato | Nessun dato | |
| VP of Administration & Real Estate and Company Secretary | no data | ₹11.57m | Nessun dato | |
| Executive Vice President of Legal | 2.6yrs | Nessun dato | Nessun dato | |
| Vice President of Ethics & Compliance | 1.6yrs | Nessun dato | Nessun dato | |
| Executive Vice President of Communications & Government Affairs | 7.4yrs | Nessun dato | Nessun dato | |
| Executive Vice-President of Regulatory Affairs | no data | Nessun dato | Nessun dato | |
| Executive Vice-President of Adult Vaccines | 2.2yrs | Nessun dato | Nessun dato | |
| Executive Vice President of General Medicines | 1.8yrs | Nessun dato | Nessun dato | |
| Commercial Head - Paediatric Vaccines | 1.7yrs | Nessun dato | Nessun dato |
2.0yrs
Durata media
Gestione esperta: Il team dirigenziale di GLAXO non è considerato esperto (durata media 1.9 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| MD & Executive Director | no data | ₹66.89m | Nessun dato | |
| Whole-Time Director & CFO | 2.4yrs | ₹68.92m | Nessun dato | |
| Non-Executive Chairperson | 5.4yrs | ₹3.25m | Nessun dato | |
| Independent Director | 2.3yrs | ₹2.65m | Nessun dato | |
| Non-Executive Independent Director | 15.2yrs | ₹2.70m | Nessun dato | |
| Non Executive Director | 7.4yrs | Nessun dato | Nessun dato | |
| Non-Executive Independent Director | 13.9yrs | ₹2.70m | Nessun dato | |
| Non-Executive Independent Director | 12.8yrs | ₹2.45m | Nessun dato | |
| Non-Executive & Independent Director | 4.3yrs | ₹2.45m | Nessun dato |
6.4yrs
Durata media
68.5yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di GLAXO sono considerati esperti (durata media dell'incarico 6.3 anni).